The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-tritylpyrrolidine ID: ALA2086865
PubChem CID: 15372343
Max Phase: Preclinical
Molecular Formula: C23H23N
Molecular Weight: 313.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Synonyms: 1-Tritylpyrrolidine | 1-Tritylpyrrolidine|N-tritylpyrrolidine|1-(triphenylmethyl)pyrrolidine|SCHEMBL2392136|CHEMBL2086865|DVFDHIZVAQOEMX-UHFFFAOYSA-N|PMID26815044-Compound-125
Canonical SMILES: c1ccc(C(c2ccccc2)(c2ccccc2)N2CCCC2)cc1
Standard InChI: InChI=1S/C23H23N/c1-4-12-20(13-5-1)23(24-18-10-11-19-24,21-14-6-2-7-15-21)22-16-8-3-9-17-22/h1-9,12-17H,10-11,18-19H2
Standard InChI Key: DVFDHIZVAQOEMX-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
12.3125 -1.1542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1375 -1.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9625 -1.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1375 -0.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1375 -1.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8543 0.0815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8546 0.9057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1396 1.3190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4228 0.9021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4260 0.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3731 -1.8710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1974 -1.8713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6107 -1.1563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1938 -0.4395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3709 -0.4426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4207 -2.3898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4204 -3.2140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1354 -3.6274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8522 -3.2104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8490 -2.3876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8276 -0.4868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0430 -0.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0430 -1.5668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8276 -1.8216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 12 1 0
1 2 1 0
12 13 2 0
6 7 1 0
13 14 1 0
2 4 1 0
14 15 2 0
15 3 1 0
7 8 2 0
5 16 2 0
16 17 1 0
8 9 1 0
17 18 2 0
2 5 1 0
18 19 1 0
9 10 2 0
19 20 2 0
20 5 1 0
1 21 1 0
10 4 1 0
2 3 1 0
3 11 2 0
4 6 2 0
21 22 1 0
22 23 1 0
23 24 1 0
24 1 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 313.44Molecular Weight (Monoisotopic): 313.1830AlogP: 5.07#Rotatable Bonds: 4Polar Surface Area: 3.24Molecular Species: BASEHBA: 1HBD: ┄#RO5 Violations: 1HBA (Lipinski): 1HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 9.85CX LogP: 5.75CX LogD: 3.34Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.61Np Likeness Score: -0.41
References 1. Singh M, Schott JT, Leon MA, Granata RT, Dhah HK, Welles JA, Boyce MA, Oseni-Olalemi HS, Mordaunt CE, Vargas AJ, Patel NV, Maitra S.. (2012) Design, synthesis and identification of a new class of triarylmethyl amine compounds as inhibitors of apolipoprotein E production., 22 (19): [PMID:22959206 ] [10.1016/j.bmcl.2012.08.009 ]